Ultrasensitive detection of prions by automated protein misfolding cyclic amplification

A prion, protein technology, applied in 0004] The present invention generally relates to pathology, a method, a composition and a device for disease, enjoying the present invention, detecting protein or prion in a sample, biochemistry and cell biology. field

Inactive Publication Date: 2008-07-09
BOARD OF RGT THE UNIV OF TEXAS SYST
View PDF12 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Subsequent refinements of this assay by other researchers have shown that prions can be continuously replicated; however, diagnostic assays still require increased levels of replication (Bieschke et al., 2004)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
  • Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
  • Ultrasensitive detection of prions by automated protein misfolding cyclic amplification

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0170] Purification of PrP from brain Sc

[0171] 1 g of brain tissue was homogenized in 5 ml cold PBS containing protease inhibitors. For PrP generated by PMCA res, after final purification, the gross sample containing normal brain homogenate used as substrate was processed in the same manner as the brain homogenate. Samples were mixed with 1 volume of 20% sarcosyl and the mixture was homogenized and sonicated until a clear preparation was obtained. Samples were centrifuged at 5000 rpm for 15 minutes at 4°C. Discard the pellet and mix the supernatant with 1 / 3 volume of PBS containing 0.1% SB-314 and centrifuge at 100,000 x g for 3 h at 4 °C in a Biosafe Optima MAX ultracentrifuge (Beckman Coulter, Fullerton, CA) . Discard the supernatant and resuspend the pellet in 600 μl of PBS containing 0.1% SB-314, 10% NaCl and sonicate. The resuspended pellet was layered on 600 ul of PBS containing 20% ​​sucrose, 10% NaCl and 0.1% SB 3-14 and centrifuged at 4°C f...

Embodiment 2

[0173] Automation: Increase throughput and reduce amplification time

[0174] The use of single-probe conventional sonicators poses practical problems for processing many samples simultaneously, as would be required for diagnostic testing. The present invention has transformed the cycle amplification system into a 96-well microplate sonicator (Misonix TM Model 3000 (Farmingdale, N.Y.)), which provides sonication to all wells simultaneously and can be programmed for automatic operation. This improvement not only reduces processing time and increases throughput, but also allows routinely more cycles than single-probe sonicators. Cross-contamination is eliminated because the probe does not penetrate the sample directly. This is important for handling infectious samples and reducing false positive results. 10 cycles of 1 hour incubation followed by 30 s sonication pulses yielded PrP Sc Significant amplification of the signal, similar to that observed with conventi...

Embodiment 3

[0176] Increased amplification efficiency through metal chelation

[0177] As part of our efforts to optimize the PMCA procedure, the inventors discovered that the relatively low levels of amplification previously observed were due in part to the presence of metal cations in the samples. The efficiency of amplification was dramatically higher when the PMCA reaction was performed in the presence of EDTA, a broad-range metal chelator.

[0178] It is well established that PrP binds copper with high affinity (and zinc to a lesser degree) and that a likely biological function of the virtually normal prion protein would be to involve Cu 2+ transport across the cell membrane (Brown and Sassoon, 2002). The results show that when Cu is added to the reactant 2+ , the positive role of EDTA in enhancing the efficiency of PMCA was lost. This effect is very clear and concentration dependent. with other divalent cations such as Ca 2+ and Mg 2+ No significant effect was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to view more

Abstract

A highly sensitive method for detecting prions in a sample is provided. These methods can be used to diagnose prion-mediated transmissible spongiform encephalopathy, such as bovine spongiform encephalopathy, Creutzfeldt-Jakob disease, scrapie or chronic wasting disease. In particular, methods for continuous automated cyclic expansion of prions are disclosed. The method is fast and highly sensitive, making it ideal for high-throughput testing.

Description

Background of the invention [0001] This application claims priority to US Provisional Patent Application Serial No. 60 / 673,302, filed April 20, 2005, which is incorporated herein by reference in its entirety. [0002] The United States Government may have certain rights in this invention pursuant to Grant No. AG024642-01 from the National Institutes of Health. [0003] I. Field of Invention [0004] The present invention relates generally to pathology, biochemistry and cell biology. Specifically, the present invention provides methods, compositions and devices for detecting proteins or prions in samples, including diagnosing prion-related diseases. [0005] II. DESCRIPTION OF RELATED TECHNOLOGY [0006] Prion diseases, also known as transmissible spongiform encephalopathies (TSE), comprise a group of fatal infectious neurodegenerative disorders that include Creutzfeldt-Jakob disease (CJD), Kuru disease, Gerstmann syndrome (GSS), Fatal familial insomnia (FFI) and sporadic f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68
CPCG01N33/6896G01N2800/2828
Inventor J·卡斯蒂拉P·萨C·索托
Owner BOARD OF RGT THE UNIV OF TEXAS SYST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products